Stepped care for obsessive-compulsive disorder: An open trial

Behaviour Research and Therapy

Volumn 48, Issue 11, 2010, Pages 1144-1149

  Gilliam, Christina M ^a   Diefenbach, Gretchen J ^a   Whiting, Sara E ^a   Tolin, David F ^a,b  

^a HARTFORD HOSPITAL   (United States)

^b YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Bibliotherapy; Cognitive behavior therapy; Cost and cost analysis; Exposure therapy; Treatment outcomes

Indexed keywords

ADULT; ARTICLE; BECK DEPRESSION INVENTORY; BEHAVIOR THERAPY; CLINICAL ARTICLE; CLINICAL GLOBAL IMPRESSION SCALE; CLINICAL PROTOCOL; CLINICAL TRIAL; COMORBIDITY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; COST CONTROL; COST EFFECTIVENESS ANALYSIS; DYSTHYMIA; FEMALE; FOLLOW UP; GENERALIZED ANXIETY DISORDER; HEALTH CARE COST; HUMAN; MALE; MEDICARE; OBSESSIVE COMPULSIVE DISORDER; PATIENT COMPLIANCE; PSYCHOEDUCATION; PSYCHOTHERAPIST; QUALITY OF LIFE; RATING SCALE; SAMPLE SIZE; SELF HELP; SOCIAL PHOBIA; TREATMENT OUTCOME;

ADULT; COGNITIVE THERAPY; COSTS AND COST ANALYSIS; FEMALE; HUMANS; IMPLOSIVE THERAPY; MALE; MIDDLE AGED; OBSESSIVE-COMPULSIVE DISORDER; PSYCHIATRIC STATUS RATING SCALES; SEVERITY OF ILLNESS INDEX; TREATMENT OUTCOME;

EID: 77957885960     PISSN: 00057967     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.brat.2010.07.010     Document Type: Article

References (34)

1. Abel J.L. Exposure with response prevention and serotonergic antidepressants in the treatment of obsessive compulsive disorder: a review and implications for interdisciplinary treatment. Behaviour Research and Therapy 1993, 31(5):463-478.
2. Abramowitz J.S., Foa E.B., Franklin M.E. Exposure and ritual prevention for obsessive-compulsive disorder: effects of intensive versus twice-weekly sessions. Journal of Consulting and Clinical Psychology 2003, 71(2):394-398.
3. American Psychiatric Association Diagnostic and statistical manual of mental disorders 2000, Author, Washington, DC. 4th Text revision ed.
4. Baillie A.J., Rapee R.M. Predicting who benefits from psychoeducation and self help for panic attacks. Behaviour Research and Therapy 2004, 42:513-527.
5. Beck A.T., Steer R.A., Brown G.K. Manual for the Beck depression inventory 1996, Psychological Corporation, Harcourt, Brace, San Antonio, TX. 2nd ed.
6. Brown T.A., Di Nardo P.A., Lehman C.L., Campbell L.A. Reliability of DSM-IV anxiety and mood disorders: implications for the classification of emotional disorders. Journal of Abnormal Psychology 2001, 110(1):49-58.
7. Bureau of Labor Statistics Occupational employment and wages summary, 2008 2009, United States Department of Labor, Washington, D.C.
8. Centers for Medicare and Medicaid Services Revised 2007 Medicare part B physician and nonphysician practitioner fee schedule 2007, First Coast Service Options, Inc, Jacksonville, FL.
9. Foa E.B., Liebowitz M.R., Kozak M.J., Davies S., Campeas R., Franklin M.E., et al. Randomized, placebo-controlled trial of exposure and ritual prevention, clomipramine, and their combination in the treatment of obsessive-compulsive disorder. American Journal of Psychiatry 2005, 162(1):151-161.
10. Foa E.B., Kozak M.J. Mastery of obsessive-compulsive disorder: A cognitive-behavioral approach (therapist guide) 1997, Oxford University Press, New York.
11. Foa E.B., Wilson R. Stop obsessing!: How to overcome your obsessions and compulsions 2001, Bantam Books, New York.
12. Goodman W.K., Price L.H., Rasmussen S.A., Mazure C., Delgado P., Heninger G.R., et al. The Yale-Brown obsessive compulsive scale. II. Validity. Archives of General Psychiatry 1989, 46(11):1012-1016.
13. Goodman W.K., Price L.H., Rasmussen S.A., Mazure C., Fleischmann R.L., Hill C.L., et al. The Yale-Brown obsessive compulsive scale. I. Development, use, and reliability. Archives of General Psychiatry 1989, 46(11):1006-1011.
14. Greist J.H., Marks I.M., Baer L., Kobak K.A., Wenzel K.W., Hirsch M.J., et al. Behavior therapy for obsessive-compulsive disorder guided by a computer or by a clinician compared with relaxation as a control. Journal of Clinical Psychiatry 2002, 63(2):138-145.
15. Guy W. Assessment manual for psychopharmacology 1976, U.S. Government Printing Office, Washington, DC.
16. Internal Revenue Service Standard mileage rate, 2008 2009, United States Department of the Treasury, Washington, DC.
17. Jacobson N.S., Truax P. Clinical significance: a statistical approach to defining meaningful change in psychotherapy research. Journal of Consulting and Clinical Psychology 1991, 59(1):12-19.
18. Kenwright M., Marks I., Graham C., Franses A., Mataix-Cols D. Brief scheduled phone support from a clinician to enhance computer-aided self-help for obsessive-compulsive disorder: randomized controlled trial. Journal of Clinical Psychology 2005, 61(12):1499-1508.
19. Kessler R.C., Chiu W.T., Demler O., Walters E.E. Prevalence, severity, and comorbidity of 12-month DSM-IV disorders in the national comorbidity survey replication. Archives of General Psychiatry 2005, 62(6):617-627.
20. Koran L.M., Hanna G.L., Hollander E., Nestadt G., Simpson H.B. Practice guideline for the treatment of patients with obsessive-compulsive disorder. American Journal of Psychiatry 2007, 164(7 Suppl.):5-53.
21. Leon A.C., Shear M.K., Portera L., Klerman G.L. Assessing impairment in patients with panic disorder: the Sheehan disability scale. Social Psychiatry and Psychiatric Epidemiology 1992, 27:78-82.
22. Little R.J., Rubin D.B. Statistical analysis with missing data 1987, Wiley, New York.
23. March J.S., Frances A., Carpenter D., Kahn D.A. The expert consensus guideline series: treatment of obsessive-compulsive disorder. Journal of Clinical Psychiatry 1997, 58(suppl. 4).
24. Mancebo M.C., Eisen J.L., Pinto A., Greenberg B.D., Dyck I.R., Rasmussen S.A. The brown longitudinal obsessive compulsive study: treatments received and patient impressions of improvement. Journal of Clinical Psychiatry 2006, 67(11):1713-1720.
25. Marks I. Behaviour therapy for obsessive-compulsive disorder: a decade of progress. Canadian Journal of Psychiatry 1997, 42(10):1021-1027.
26. McLean P.D., Whittal M.L., Thordarson D.S., Taylor S., Sochting I., Koch W.J., et al. Cognitive versus behavior therapy in the group treatment of obsessive-compulsive disorder. Journal of Consulting and Clinical Psychology 2001, 69(2):205-214.
27. Otto M.W., Pollack M.H., Maki K.M. Empirically supported treatments for panic disorder: costs, benefits, and stepped care. Journal of Consulting and Clinical Psychology 2000, 68(4):556-563.
28. Satterthwaite F.W. An approximate distribution of estimates of variance components. Biometrics Bulletin 1946, 2:110-114.
29. Simpson H.B., Huppert J.D., Petkova E., Foa E.B., Liebowitz M.R. Response versus remission in obsessive-compulsive disorder. Journal of Clinical Psychiatry 2006, 67(2):269-276.
30. SPSS Inc. SPSS missing value analysis 7.5 1997, Chicago, IL.
31. Tolin D.F., Diefenbach G.J., Maltby N., Hannan S.E. Stepped care for obsessive-compulsive disorder: a pilot study. Cognitive and Behavioral Practice 2005, 12:403-414.
32. Tolin D.F., Hannan S., Maltby N., Diefenbach G.J., Worhunsky P., Brady R.E. A randomized controlled trial of self-directed versus therapist-directed cognitive-behavioral therapy for obsessive-compulsive disorder patients with prior medication trials. Behavior Therapy 2007, 38(2):179-191.
33. Torres A.R., Prince M.J., Bebbington P.E., Bhugra D.K., Brugha T.S., Farrell M., et al. Treatment seeking by individuals with obsessive-compulsive disorder from the British psychiatric morbidity survey of 2000. Psychiatric Services 2007, 58(7):977-982.
34. van Balkom A.J.L.M., van Oppen P., Vermeulen A.W.A., van Dyck R., Nauta M.C.E., Vorst H.C.M. A meta-analysis on the treatment of obsessive-compulsive disorders: A comparison of antidepressants, behavior, and cognitive therapy. Clinical Psychology Review 1994, 14:359-381.